These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14862322)

  • 1. [Investigations on the role of the nervous system in the pathomechanism of acute heart insufficiency. II. Effect of ergotamine derivatives on vascular pressure].
    HALMAGYI D; FELKAI B; IVANYI J; HETENYI G; SZEITZ K
    Magy Belorv Arch Ideggyogy Szle; 1951; 4(2):56-60. PubMed ID: 14862322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Xanthic derivatives inhibiting the inversion by ergotamine of the hypotensor effects of isopropyladrenaline and of 3-4-dioxyephedrine].
    HAZARD R; BEAUVALLET M; GIUDICELLI R
    C R Seances Soc Biol Fil; 1951 Jan; 145(1-2):78-80. PubMed ID: 14839877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of associated acetylcholine-atropine and acetylcholine-ergotamine on essential hypotension].
    RIVASI P
    Rass Neurol Veg; 1950 Jun; 8(2):138-49. PubMed ID: 14781409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of associated acetylcholine-atropine and acetylcholine-ergotamine in essential hypertension].
    RIVASI P
    Rass Neurol Veg; 1950 Jun; 8(2):150-61. PubMed ID: 14781410
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of headache in otorhinolaryngology with new ergotamine derivatives].
    RABECHAULT ; SEGUINARD
    Rev Laryngol Otol Rhinol (Bord); 1953; 74(3-4):286-95. PubMed ID: 13075292
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ergot and its alkaloids; its oxytocic action and effects on the vegetative nervous system and on blood pressure].
    MENESES HOYOS J
    Medicina (Mex); 1955 Oct; 35(734):473-8. PubMed ID: 13279442
    [No Abstract]   [Full Text] [Related]  

  • 7. [VASCULAR ACTION OF ERGOT ALKALOIDS].
    BRUGGER A; ESPLUGUES J
    Med Esp; 1963 Nov; 50():290-3. PubMed ID: 14113576
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of dihydrated ergot alkaloids in hypertension].
    KAISER K; MARTINI P
    Dtsch Med Wochenschr; 1950 Nov; 75(46):1566-8. PubMed ID: 14793182
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of dihydrated ergot alkaloids in hypertension].
    KAISER K; MARTINI P
    Dtsch Med Wochenschr; 1950 Nov; 75(45):1516-24; contd. PubMed ID: 14793170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of hydrated ergot alkaloids on arterial and venous pressure].
    HAMMERSCHMIDT D; ODENTHAL F
    Z Kreislaufforsch; 1950 Mar; 39(5-6):150-60. PubMed ID: 15425199
    [No Abstract]   [Full Text] [Related]  

  • 11. [For Analysis of the Blood pressure effects of natural and dihydrogenated Ergot Alkaloids].
    ROTHLIN E
    Experientia; 1949 Feb; 5(2):78. PubMed ID: 18113654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Obliteration of the pressor activity of vaso-dilative adrenalin derivatives by ergotamine].
    LUDWIGS N
    Arch Int Pharmacodyn Ther; 1952 Sep; 91(3-4):356-65. PubMed ID: 13008514
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE EFFECT OF HYDROGENATED ERGOT ALKALOIDS ON THE PROCESS OF BLOOD COAGULATION].
    AKOPOV Ie; LEVIN IaL; IADROVA VM
    Biull Eksp Biol Med; 1964 Sep; 58():88-91. PubMed ID: 14273472
    [No Abstract]   [Full Text] [Related]  

  • 14. [Basal metabolism in hypertension during treatment with hydrated ergot alkaloids].
    JAKOB R
    Z Kreislaufforsch; 1950 Dec; 39(23-24):729-36. PubMed ID: 14818306
    [No Abstract]   [Full Text] [Related]  

  • 15. Ergot alkaloid mycotoxins: physiological effects, metabolism and distribution of the residual toxin in mice.
    Reddy P; Hemsworth J; Guthridge KM; Vinh A; Vassiliadis S; Ezernieks V; Spangenberg GC; Rochfort SJ
    Sci Rep; 2020 Jun; 10(1):9714. PubMed ID: 32546814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MODIFICATIONS OF THE VASCULAR EFFECTS OF THE GANGLIOPLEGICS BY THE ERGOT ALKALOIDS].
    BRUGGER A; ESPLUGUES J
    Med Esp; 1963 Dec; 50():383-96. PubMed ID: 14112389
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of dihydroergotamine on the circulatory system].
    KRZEMINSKA-ŁAWKOWICZOWA I
    Pol Tyg Lek (Wars); 1951 Apr; 6(17):558-69. PubMed ID: 14864188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hydergin therapy of hypertension].
    GAST W; HUEBER EF
    Wien Klin Wochenschr; 1950 Dec; 62(48):900-3. PubMed ID: 14828723
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute coronary insufficiency pattern following intravenous ergotamine studies; report of a case.
    McNERNEY JJ; LEEDHAM CL
    Am Heart J; 1950 Apr; 39(4):629-32. PubMed ID: 15410668
    [No Abstract]   [Full Text] [Related]  

  • 20. [MODIFICATIONS OF THE VASCULAR EFFECTS OF ERGOT ALKALOIDS BY GANGLIOPLEGICS].
    BRUGGER A; ESPLUGUES J
    Med Esp; 1964 Jan; 51():23-35. PubMed ID: 14135750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.